GALECTIN THERAPEUTICS INC.

(GALT)
  Report
Delayed Nasdaq  -  05/17 04:00:00 pm EDT
1.350 USD   +7.14%
05/17HC Wainwright Adjusts Price Target on Galectin Therapeutics to $11 From $14, Reiterates Buy Rating
MT
05/16Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
AQ
05/16GALECTIN THERAPEUTICS INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart GALECTIN THERAPEUTICS INC.
Upcoming events on GALECTIN THERAPEUTICS INC.
08/15/22 Interim 2022 Earnings Release (Projected)
11/15/22 Q3 2022 Earnings Release (Projected)
03/30/23 FY 2022 Earnings Release (Projected)
Past events on GALECTIN THERAPEUTICS INC.
05/13/22 Q1 2022 Earnings Release (Projected)
03/31/22 | 08:00am FY 2021 Earnings Release
01/10/22 | 07:00am H.C. Wainwright BioConnect Conference
12/03/21 | 11:00am Annual General Meeting
11/15/21 | 08:00am Q3 2021 Earnings Release
11/12/21 AASLD The Liver Meeting
09/13/21 | 07:00am H.C. Wainwright Global Investment Conference
08/16/21 | 09:00am Interim 2021 Earnings Release
05/17/21 | 08:00am Q1 2021 Earnings Release
03/31/21 | 08:00am FY 2020 Earnings Release
Past dividends on GALECTIN THERAPEUTICS INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-16,2
-18,6
12%
-13,6
-13,5
-0,69%
-13,4
-11,8
-14%
-23,4
-24,6
4,7%
-30,2
-34,0
11%
 
-45,4
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-16,2
-18,0
9,7%
-13,9
-13,8
-0,62%
-13,3
-11,6
-15%
-23,5
-24,5
4,4%
-30,5
-34,7
12%
 
-46,3
 
Net income
M $
Released
Forecast
Spread
-17,5
-18,7
6,6%
-15,0
-14,4
-4,6%
-20,2
-15,0
-34%
-23,6
-24,6
4,1%
-30,7
-34,9
12%
 
-46,4
 
EPS
$
Released
Forecast
Spread
-0,49
-0,51
3,9%
-0,38
-0,37
-4,1%
-0,39
-0,35
-11%
-0,41
-0,43
4,7%
-0,52
-0,59
12%
 
-0,75
 
Announcement Date03/29/201803/06/201903/16/202003/31/202103/31/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-6,32
-9,60
34%
-8,19
-10,4
21%
-8,24
-10,2
19%
-7,43
-11,2
34%
-9,94

 
 
-11,0
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-6,34
-9,55
34%
-8,45
-10,3
18%
-8,52
-10,4
18%
-7,22
-11,4
37%
-9,93

 
 
-11,3
 
Net income
M $
Released
Forecast
Spread
-6,34
-9,55
34%
-8,51
-10,3
18%
-8,56
-10,4
18%
-7,29
-11,5
37%
-9,92
-8,38
-18%
 
-11,3
 
EPS
$
Released
Forecast
Spread
-0,11
-0,17
35%
-0,15
-0,18
17%
-0,14
-0,18
22%
-0,12
-0,19
37%
-0,17

 
 
-0,19
 
Announcement Date05/17/202108/16/202111/15/202103/31/202205/16/2022-
Previous year Next Year
Upcoming sector events for GALECTIN THERAPEUTICS INC.
More events
Past sector events for GALECTIN THERAPEUTICS INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise